Lv1
50 积分 2026-01-09 加入
[Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)]
7天前
已关闭
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
8天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
8天前
已完结
Accelerometer-derived ‘weekend warrior’ physical activity and incident cardiovascular disease among people with diabetes
2个月前
已完结
The associations of weekend warrior and other physical activity patterns with the risk of all-cause and cardiovascular disease mortality in people with diabetes mellitus and chronic kidney disease: from NHANES 2007–2020
2个月前
已完结
皖公网安备34019202002308
